Significance of the Ki-67 proliferation index in the assessment of the therapeutic response to cisplatin-based chemotherapy in patients with advanced cervical cancer
Significance of the Ki-67 proliferation index in the assessment of the therapeutic response to cisplatin-based chemotherapy in patients with advanced cervical cancer
复制标题
DOI:
10.26355/eurrev_201808_15710
复制
发表时间:
2018-08-01
影响因子:
3.3
通讯作者:
Zivadinovic, A.
中科院分区:
文献类型:
--
作者:
Krtinic, D.;Zivadinovic, R.;Zivadinovic, A.
OBJECTIVE: The purposes of this study were to examine the therapeutic response of advanced cervical cancerto Ki-67 proliferative index (Ki-67 PI) dependent cisplatin chemotherapy, and to determine KI-67 PI referential value that is expected to provides satisfactory therapeutic response of cervical cancer to cisplatin chemotherapy.PATIENTS AND METHODS: This prospective study enrolled 59 patients treated for cervical cancer at Clinic for Oncology, Clinical Center Nis, Serbia. According to the obtained Ki-67 PI values, patients were divided into three groups, and all the patients received the same cytostatic, cisplatin. Therapeutic response to chemotherapy was evaluated in relation to disease progression presence or absence and progression-free survival after a year follow-up since the first chemotherapy.RESULTS: Survival rate increases with an increase of Ki-67 PI by Kaplan-Meier survival analysis, meaning that survival rate is statistically significantly shorter in the group of patients with Ki-67 PI < 40% in comparison to patients from other two groups (p=0.010). Mann-Whitney test confirmed a statistically significant increase in survival rate among the groups of patients formed according to Ki-67 PI (p= 40%).